25 results
8-K
EX-10.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
and pronouns stated in either the masculine, the feminine or neuter gender shall include the masculine, feminine and neuter, (c) the words “hereof
8-K
EX-10.2
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
in either the masculine, the feminine or neuter gender shall include the masculine, feminine and neuter, (c) the words “hereof,” “herein” and words
8-K
EX-99.1
yfn929t
29 Jul 21
Stock Purchase Agreement
4:15pm
DEF 14A
9ry1b463icv857c
29 Apr 19
Definitive proxy
12:00am
424B4
7tez821k1hq3
18 Jul 18
Prospectus supplement with pricing info
5:27pm
S-1/A
EX-10.8
1recj ux9n9
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
g05rkhbc gvhi0
9 Jul 18
IPO registration (amended)
6:10am
S-1
EX-10.6
2gs8n8d8kla6
22 Jun 18
IPO registration
4:07pm
S-1
EX-10.7
l9gfn7
22 Jun 18
IPO registration
4:07pm
S-1
u2bbb
22 Jun 18
IPO registration
4:07pm
S-1
EX-10.9
9v7255sd09d53e4
22 Jun 18
IPO registration
4:07pm
DRS/A
EX-10.6
7jcxe09chsibxxec88r5
11 Jun 18
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
kuf560dai7wo59aal2
11 Jun 18
Draft registration statement (amended)
12:00am